Chemotherapy plus or minus Cetuximab Modulates Peripheral Immune Responses in Metastatic Colorectal...
Chemotherapy plus or minus Cetuximab Modulates Peripheral Immune Responses in Metastatic Colorectal Cancer
About this item
Full title
Author / Creator
Journal title
Language
English
Formats
More information
Scope and Contents
Contents
Objective: To identify changes in peripheral immune responses in patients with metastatic colorectal cancer (mCRC) treated with irinotecan/5-fluorouracil/leucovorin (IFL) alone or in combination with cetuximab (C-IFL). Methods: Peripheral blood mononuclear cells (PBMCs) collected from healthy donors (n = 20) and patients with mCRC receiving treatme...
Alternative Titles
Full title
Chemotherapy plus or minus Cetuximab Modulates Peripheral Immune Responses in Metastatic Colorectal Cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1776661517
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1776661517
Other Identifiers
ISSN
0030-2414
E-ISSN
1423-0232
DOI
10.1159/000343282